• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于瘤内亚区域的乳腺动态对比增强磁共振成像纹理分析预测HER2 2+状态

Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status.

作者信息

Lu Hecheng, Yin Jiandong

机构信息

School of Medicine and Bioinformatics Engineering, Northeastern University, Shenyang, China.

Department of Radiology, ShengJing Hospital of China Medical University, Shenyang, China.

出版信息

Front Oncol. 2020 Apr 21;10:543. doi: 10.3389/fonc.2020.00543. eCollection 2020.

DOI:10.3389/fonc.2020.00543
PMID:32373531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7186477/
Abstract

Breast tumor heterogeneity is related to risk factors that lead to aggressive tumor growth; however, such heterogeneity has not been thoroughly investigated. To evaluate the performance of texture features extracted from heterogeneity subregions on subtraction MRI images for identifying human epidermal growth factor receptor 2 (HER2) 2+ status of breast cancers. Seventy-six patients with HER2 2+ breast cancer who underwent dynamic contrast-enhanced magnetic resonance imaging were enrolled, including 42 HER2 positive and 34 negative cases confirmed by fluorescence hybridization. The lesion area was delineated semi-automatically on the subtraction MRI images at the second, fourth, and sixth phases (P-1, P-2, and P-3). A regionalization method was used to segment the lesion area into three subregions (rapid, medium, and slow) according to peak arrival time of the contrast agent. We extracted 488 texture features from the whole lesion area and three subregions independently. Wrapper, least absolute shrinkage and selection operator (LASSO), and stepwise methods were used to identify the optimal feature subsets. Univariate analysis was performed as well as support vector machine (SVM) with a leave-one-out-based cross-validation method. The area under the receiver operating characteristic curve (AUC) was calculated to evaluate the performance of the classifiers. In univariate analysis, the variance from medium subregion at P-2 was the best-performing feature for distinguishing HER2 2+ status (AUC = 0.836); for the whole lesion region, the variance at P-2 achieved the best performance (AUC = 0.798). There was no significant difference between the two methods ( = 0.271). In the machine learning with SVM, the best performance (AUC = 0.929) was achieved with LASSO from rapid subregion at P-2; for the whole region, the highest AUC value was 0.847 obtained at P-2 with LASSO. The difference was significant between the two methods ( = 0.021). The texture analysis of heterogeneity subregions based on intratumoral regionalization method showed potential value for recognizing HER2 2+ status in breast cancer.

摘要

乳腺肿瘤异质性与导致肿瘤侵袭性生长的风险因素相关;然而,这种异质性尚未得到充分研究。为了评估从减法MRI图像的异质性子区域提取的纹理特征在识别乳腺癌人表皮生长因子受体2(HER2)2+状态方面的性能。招募了76例接受动态对比增强磁共振成像的HER2 2+乳腺癌患者,其中包括通过荧光杂交确认的42例HER2阳性和34例阴性病例。在减法MRI图像的第二、第四和第六阶段(P-1、P-2和P-3)半自动勾勒病变区域。采用一种区域划分方法根据对比剂的峰值到达时间将病变区域分割为三个子区域(快速、中等和缓慢)。我们分别从整个病变区域和三个子区域提取了488个纹理特征。采用包装法、最小绝对收缩和选择算子(LASSO)以及逐步法来识别最佳特征子集。进行单因素分析以及采用基于留一法交叉验证方法的支持向量机(SVM)。计算受试者工作特征曲线(AUC)下的面积以评估分类器的性能。在单因素分析中,P-2时中等子区域的方差是区分HER2 2+状态的最佳性能特征(AUC = 0.836);对于整个病变区域,P-2时的方差表现最佳(AUC = 0.798)。两种方法之间无显著差异(= 0.271)。在使用SVM的机器学习中,P-2时快速子区域的LASSO实现了最佳性能(AUC = 0.929);对于整个区域,P-2时LASSO获得的最高AUC值为0.847。两种方法之间的差异具有显著性(= 0.021)。基于肿瘤内区域划分方法的异质性子区域纹理分析显示出在识别乳腺癌HER2 2+状态方面的潜在价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/574326a07e3c/fonc-10-00543-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/7e3aa6662aef/fonc-10-00543-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/1d72050b0360/fonc-10-00543-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/3b9fa1c73c5d/fonc-10-00543-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/9449231cb704/fonc-10-00543-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/574326a07e3c/fonc-10-00543-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/7e3aa6662aef/fonc-10-00543-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/1d72050b0360/fonc-10-00543-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/3b9fa1c73c5d/fonc-10-00543-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/9449231cb704/fonc-10-00543-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfcf/7186477/574326a07e3c/fonc-10-00543-g0005.jpg

相似文献

1
Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status.基于瘤内亚区域的乳腺动态对比增强磁共振成像纹理分析预测HER2 2+状态
Front Oncol. 2020 Apr 21;10:543. doi: 10.3389/fonc.2020.00543. eCollection 2020.
2
Preliminary study on discriminating HER2 2+ amplification status of breast cancers based on texture features semi-automatically derived from pre-, post-contrast, and subtraction images of DCE-MRI.基于 DCE-MRI 增强前后图像和减影图像的纹理特征半自动鉴别乳腺癌 HER2 2+扩增状态的初步研究。
PLoS One. 2020 Jun 17;15(6):e0234800. doi: 10.1371/journal.pone.0234800. eCollection 2020.
3
Texture Analysis of DCE-MRI Intratumoral Subregions to Identify Benign and Malignant Breast Tumors.动态对比增强磁共振成像(DCE-MRI)瘤内亚区域的纹理分析用于鉴别乳腺良恶性肿瘤
Front Oncol. 2021 Jul 8;11:688182. doi: 10.3389/fonc.2021.688182. eCollection 2021.
4
DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.基于肿瘤亚区划分的 DCE-MRI 纹理分析预测雌激素受体阳性乳腺癌的 Ki-67 状态。
J Magn Reson Imaging. 2018 Jul;48(1):237-247. doi: 10.1002/jmri.25921. Epub 2017 Dec 8.
5
Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer.基于瘤内亚区域的动态对比增强磁共振成像放射组学分析用于预测管腔型和非管腔型乳腺癌
Quant Imaging Med Surg. 2023 Oct 1;13(10):6735-6749. doi: 10.21037/qims-22-1073. Epub 2023 Sep 11.
6
Texture Analysis Using Semiquantitative Kinetic Parameter Maps from DCE-MRI: Preoperative Prediction of HER2 Status in Breast Cancer.使用DCE-MRI的半定量动力学参数图进行纹理分析:乳腺癌中HER2状态的术前预测
Front Oncol. 2021 Jun 8;11:675160. doi: 10.3389/fonc.2021.675160. eCollection 2021.
7
The Potential Use of DCE-MRI Texture Analysis to Predict HER2 2+ Status.动态对比增强磁共振成像纹理分析预测人表皮生长因子受体2(HER2)2+状态的潜在应用
Front Oncol. 2019 Apr 12;9:242. doi: 10.3389/fonc.2019.00242. eCollection 2019.
8
Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.动态对比增强(DCE)-MRI的肿瘤内分区及纹理分析可识别相关肿瘤亚区域,以预测乳腺癌对新辅助化疗的病理反应。
J Magn Reson Imaging. 2016 Nov;44(5):1107-1115. doi: 10.1002/jmri.25279. Epub 2016 Apr 15.
9
Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer.基于多参数磁共振成像的放射组学模型预测乳腺癌分子亚型及雄激素受体表达
Front Oncol. 2021 Aug 18;11:706733. doi: 10.3389/fonc.2021.706733. eCollection 2021.
10
Invasive ductal breast cancer molecular subtype prediction by MRI radiomic and clinical features based on machine learning.基于机器学习,通过MRI影像组学和临床特征预测浸润性导管乳腺癌分子亚型
Front Oncol. 2022 Sep 12;12:964605. doi: 10.3389/fonc.2022.964605. eCollection 2022.

引用本文的文献

1
Using baseline MRI radiomics to predict the tumor shrinkage patterns in HR-Positive, HER2-Negative Breast Cancer.利用基线MRI影像组学预测激素受体阳性、人表皮生长因子受体2阴性乳腺癌的肿瘤缩小模式。
Front Oncol. 2025 Jul 30;15:1539644. doi: 10.3389/fonc.2025.1539644. eCollection 2025.
2
Development and validation of an intratumoral-peritumoral deep transfer learning fusion model for differentiating BI-RADS 3-4 breast nodules.用于鉴别BI-RADS 3-4级乳腺结节的瘤内-瘤周深度迁移学习融合模型的开发与验证
Gland Surg. 2025 Apr 30;14(4):658-669. doi: 10.21037/gs-24-457. Epub 2025 Apr 25.
3
Whole tumour- and subregion-based radiomics of contrast-enhanced mammography in differentiating HER2 expression status of invasive breast cancers: A double-centre pilot study.

本文引用的文献

1
Overview of radiomics in breast cancer diagnosis and prognostication.乳腺癌诊断和预后中的放射组学概述。
Breast. 2020 Feb;49:74-80. doi: 10.1016/j.breast.2019.10.018. Epub 2019 Nov 6.
2
Assessing the Bone Age of Children in an Automatic Manner Newborn to 18 Years Range.自动评估新生儿至 18 岁儿童的骨龄。
J Digit Imaging. 2020 Apr;33(2):399-407. doi: 10.1007/s10278-019-00209-z.
3
Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.基于动态对比增强 MRI 和基因表达谱的乳腺癌放射组学研究。
基于对比增强乳腺摄影术的全肿瘤和亚区放射组学在鉴别浸润性乳腺癌 HER2 表达状态中的作用:一项双中心初步研究。
Br J Cancer. 2024 Nov;131(10):1613-1622. doi: 10.1038/s41416-024-02871-9. Epub 2024 Oct 9.
4
Radiomics Machine Learning Analysis of Clear Cell Renal Cell Carcinoma for Tumour Grade Prediction Based on Intra-Tumoural Sub-Region Heterogeneity.基于肿瘤内亚区域异质性的透明细胞肾细胞癌肿瘤分级预测的影像组学机器学习分析
Cancers (Basel). 2024 Apr 10;16(8):1454. doi: 10.3390/cancers16081454.
5
Deconvolution-Based Pharmacokinetic Analysis to Improve the Prediction of Pathological Information of Breast Cancer.基于去卷积的药代动力学分析,改善乳腺癌病理信息预测。
J Imaging Inform Med. 2024 Feb;37(1):13-24. doi: 10.1007/s10278-023-00915-9. Epub 2024 Jan 10.
6
Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer.基于瘤内亚区域的动态对比增强磁共振成像放射组学分析用于预测管腔型和非管腔型乳腺癌
Quant Imaging Med Surg. 2023 Oct 1;13(10):6735-6749. doi: 10.21037/qims-22-1073. Epub 2023 Sep 11.
7
The use of radiomics in magnetic resonance imaging for the pre-treatment characterisation of breast cancers: A scoping review.磁共振成像中放射组学在乳腺癌治疗前特征描述中的应用:范围综述。
J Med Radiat Sci. 2023 Dec;70(4):462-478. doi: 10.1002/jmrs.709. Epub 2023 Aug 3.
8
Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer.动态对比增强磁共振成像参数图和表观扩散系数图的影像组学预测乳腺癌Ki-67状态
Front Oncol. 2022 Nov 25;12:847880. doi: 10.3389/fonc.2022.847880. eCollection 2022.
9
Artificial intelligence in tumor subregion analysis based on medical imaging: A review.基于医学影像的肿瘤亚区分析中的人工智能:综述。
J Appl Clin Med Phys. 2021 Jul;22(7):10-26. doi: 10.1002/acm2.13321. Epub 2021 Jun 24.
Cancer Imaging. 2019 Jul 15;19(1):48. doi: 10.1186/s40644-019-0233-5.
4
Rectal cancer: can T2WI histogram of the primary tumor help predict the existence of lymph node metastasis?直肠癌:原发肿瘤 T2WI 直方图能否帮助预测淋巴结转移的存在?
Eur Radiol. 2019 Dec;29(12):6469-6476. doi: 10.1007/s00330-019-06328-z. Epub 2019 Jul 5.
5
Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer.基于 DCE-MRI 无监督分解的肿瘤及周围实质成像异质性的放射组学分析预测乳腺癌分子亚型。
Eur Radiol. 2019 Aug;29(8):4456-4467. doi: 10.1007/s00330-018-5891-3. Epub 2019 Jan 7.
6
Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.使用定量超声、纹理和分子特征对接受新辅助化疗的乳腺癌患者进行反应监测。
PLoS One. 2018 Jan 3;13(1):e0189634. doi: 10.1371/journal.pone.0189634. eCollection 2018.
7
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.磁共振成像纹理分析在鉴别管腔A型和管腔B型乳腺癌分子亚型中的应用——一项可行性研究
BMC Med Imaging. 2017 Dec 29;17(1):69. doi: 10.1186/s12880-017-0239-z.
8
DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.基于肿瘤亚区划分的 DCE-MRI 纹理分析预测雌激素受体阳性乳腺癌的 Ki-67 状态。
J Magn Reson Imaging. 2018 Jul;48(1):237-247. doi: 10.1002/jmri.25921. Epub 2017 Dec 8.
9
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.基于乳腺动态对比增强磁共振成像的瘤内和瘤周影像组学对新辅助化疗病理完全缓解的治疗前预测
Breast Cancer Res. 2017 May 18;19(1):57. doi: 10.1186/s13058-017-0846-1.
10
Gender Recognition from Human-Body Images Using Visible-Light and Thermal Camera Videos Based on a Convolutional Neural Network for Image Feature Extraction.基于卷积神经网络进行图像特征提取,利用可见光和热成像相机视频从人体图像中识别性别
Sensors (Basel). 2017 Mar 20;17(3):637. doi: 10.3390/s17030637.